Leading GSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer TrialsOrphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers ...

Prince Harry will attend the 2024 WellChild awards, marking his first time back in the United Kingdom since going to the ...

Elraglusib is a Class-Leading GSK-3ß Inhibitor with a Novel ... and seven years of post-approval marketing exclusivity. 1 American Cancer Society. Cancer Facts & Figures 2024. Atlanta: American Cancer ...

Vaccines for the Fall and Winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines ...

Iberdrola O: 8; L: 8; I: 8; Total: 24 In November 2023, the energy group’s legal team launched a pro-bono programme to ...

Welcome to the C3 AI's first quarter fiscal year 2025 conference call. At this time, all participants are in a listen-only ...

Focused on Return to Profitability: 18.3% reduction in net loss to $6.8 million in the first nine months of 2024, down from $8.3 million in the same period of 2023; achieved 50.6% improvement over ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Without revealing specific details, GSK announced that it is terminating the development of its investigational herpes ...